NovoCure Ltd.

352 articles about NovoCure Ltd.

• NovoCure Ltd. Adds Three Senior Oncology Executives to its Global Management Team

  12/19/2011

• NovoCure Ltd. Establishes Initial Clinical Centers of Excellence for Treatment of Recurrent Glioblastoma Multiforme with Tumor Treating Fields (TTFields)(TM) Therapy

  12/2/2011

• NovoCure Ltd. Release: Updated Survival Data from Study Comparing TTF(TM) (Tumor Treating Fields) Therapy to Best Standard Chemotherapy for Recurrent Glioblastoma Reported at the 16th Annual Scientific Meeting of the Society for NeuroOncology

  11/21/2011

• NovoCure Ltd. Announces Data Presentations of NovoTTF-100A System(TM) at the 16th Annual Scientific Meeting of the Society for NeuroOncology

  11/18/2011

• NovoCure Ltd. Expands Board of Directors with Appointment of Gabriel Leung

  10/5/2011

• NovoCure Ltd. Announces Long-Term Supply Agreement With ITT Corporation for Ceramic Sensor Technology

  8/4/2011

• FDA Approves the NovoCure Ltd.'s NovoTTF-100A System for the Treatment of Patients With Recurrent Glioblastoma Multiforme (GBM) Brain Tumors

  4/18/2011

• FDA Panel Backs NovoCure Ltd. Experimental Brain-Cancer-Treatment Device

  3/18/2011

• NovoCure Ltd. Reports Data Showing TTF Therapy in Combination With Chemotherapy Has the Potential to Increase Overall Survival for Patients With Advanced Non-Small Cell Lung Cancer

  10/11/2010

• Successful Phase III Clinical Trial Results Reported for NovoCure Ltd.'s Novel Medical Device for Treatment of Recurrent Glioblastoma

  6/7/2010

• NovoCure Ltd. Announces the Closing of a Financing Round Including New Investors Pfizer Inc. (JOBS), Johnson & Johnson

  9/29/2009

• Studies Show Novel Device From NovoCure Ltd. May Enhance Chemotherapy Treatment In Brain Tumors

  11/25/2008